{"id":692716,"date":"2022-10-06T06:10:40","date_gmt":"2022-10-06T10:10:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/"},"modified":"2022-10-06T06:10:40","modified_gmt":"2022-10-06T10:10:40","slug":"centogene-to-participate-in-upcoming-partnering-conferences-in-october","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/","title":{"rendered":"CENTOGENE to Participate in Upcoming Partnering Conferences in October"},"content":{"rendered":"
\n

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule one-on-one meetings.<\/p>\n

Please see additional details below:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n European Society of Gene & Cell Therapy (ESGCT) Annual Congress<\/strong>
\n \n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Dates:<\/strong>\n <\/td>\nOctober 11-14, 2022<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Location:<\/strong>\n <\/td>\nEdinburgh International Conference Centre (EICC), U.K.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Format:<\/strong>\n <\/td>\nOne-on-one meetings<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\nTo learn more about the ESGCT Annual Congress, please visit the event website (https:\/\/www.esgctcongress.com\/<\/a>). To set up a one-on-one meeting with the CENTOGENE team, contact BD@centogene.com<\/a>.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n BIO-Europe\u00ae<\/strong>
\n \n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Dates:<\/strong>\n <\/td>\nOctober 24-26, 2022<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Location:<\/strong>\n <\/td>\nLeipzig Messe, Germany \/ Virtual<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Format:<\/strong>\n <\/td>\nPresentation, one-on-one meetings<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Presentation:<\/strong>\n <\/td>\nCENTOGENE Digital Company Presentation<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Speaker:<\/strong>\n <\/td>\nKim Stratton, CENTOGENE CEO<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\nFor information about BIO-Europe, please visit the event website (https:\/\/informaconnect.com\/bioeurope\/<\/a>). Book an in-person or virtual meeting directly with\u00a0CENTOGENE in advance by contacting BD@centogene.com<\/a>, or via the PartneringONE\u00ae Platform.<\/td>\n<\/tr>\n<\/table>\n

\n About<\/strong>
\n CENTOGENE<\/strong>
\n \n <\/p>\n

CENTOGENE (Nasdaq: CNTG) is transforming real-world clinical, genetic, and multiomic data to enable better health outcomes for patients with rare and neurodegenerative diseases. For over 15 years, CENTOGENE has been providing diagnostic insights to patients with genetic diseases through our network of nearly 30,000 active physicians. CENTOGENE now believes its Biodatabank is the world\u2019s largest real-world data repository of corresponding patients from more than 120 countries. Simplified logistics solutions, including CentoCard\u00ae<\/sup> for sending biosamples, and our ISO, CAP, & CLIA certified state-of-the-art multiomic reference labs offer patients rapid and reliable diagnoses to support the identification and personalization of their treatments. Ultimately, offering the best treatment for patients involves developing new or better therapies. We are de-risking orphan drug discovery and development by partnering with more than 30 biopharma in target & drug screening, clinical development, market access and expansion. CENTOGENE engages in biodata partnerships with our Biodata Licenses and Insight Reports.<\/p>\n

To discover more about our products, pipeline, and patient-driven purpose, visit www.centogene.com<\/u><\/a> and follow us on\u202fLinkedIn<\/u><\/a>.<\/p>\n

\n Forward-Looking Statements <\/strong>\n <\/p>\n

This press release contains \u201cforward-looking statements\u201d within the meaning of the U.S. federal securities laws. Statements contained herein that are not clearly historical in nature are forward-looking, and the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinues,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cproject,\u201d and similar expressions and future or conditional verbs such as \u201cwill,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201ccan,\u201d and \u201cmay,\u201d are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause CENTOGENE\u2019s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, negative economic and geopolitical conditions and instability and volatility in the worldwide financial markets, possible changes in current and proposed legislation, regulations and governmental policies, pressures from increasing competition and consolidation in our industry, the expense and uncertainty of regulatory approval, including from the U.S. Food and Drug Administration, our reliance on third parties and collaboration partners, including our ability to manage growth and enter into new client relationships, our dependency on the rare disease industry, our ability to manage international expansion, our reliance on key personnel, our reliance on intellectual property protection, fluctuations of our operating results due to the effect of exchange rates, our ability to streamline cash usage, our requirement for additional financing, or other factors. For further information on the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to CENTOGENE\u2019s business in general, see CENTOGENE\u2019s risk factors set forth in CENTOGENE\u2019s Form 20-F filed on March 31, 2022, with the Securities and Exchange Commission (the \u201cSEC\u201d) and subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and CENTOGENE\u2019s specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.<\/p>\n

\n Media Contact:<\/strong><\/p>\n

CENTOGENE<\/strong>
\n
Lennart Streibel\u00a0
Investor Relations\u00a0
Investor.Relations@centogene.com<\/a><\/p>\n

Ben Legg\u00a0
Corporate Communications\u00a0
Press@centogene.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule one-on-one meetings. Please see additional details below: European Society of Gene & Cell Therapy (ESGCT) Annual Congress \u00a0 Dates: October 11-14, 2022 \u00a0 Location: Edinburgh International Conference Centre (EICC), U.K. \u00a0 Format: One-on-one meetings \u00a0 \u00a0 \u00a0 \u00a0 To learn more about the ESGCT Annual Congress, please visit the event website (https:\/\/www.esgctcongress.com\/). To set up a one-on-one meeting with the CENTOGENE … <\/p>\n

Continue reading “CENTOGENE to Participate in Upcoming Partnering Conferences in October”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692716","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule one-on-one meetings. Please see additional details below: European Society of Gene & Cell Therapy (ESGCT) Annual Congress \u00a0 Dates: October 11-14, 2022 \u00a0 Location: Edinburgh International Conference Centre (EICC), U.K. \u00a0 Format: One-on-one meetings \u00a0 \u00a0 \u00a0 \u00a0 To learn more about the ESGCT Annual Congress, please visit the event website (https:\/\/www.esgctcongress.com\/). To set up a one-on-one meeting with the CENTOGENE … Continue reading "CENTOGENE to Participate in Upcoming Partnering Conferences in October"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T10:10:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CENTOGENE to Participate in Upcoming Partnering Conferences in October\",\"datePublished\":\"2022-10-06T10:10:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/\"},\"wordCount\":706,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/\",\"name\":\"CENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=\",\"datePublished\":\"2022-10-06T10:10:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE to Participate in Upcoming Partnering Conferences in October\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/","og_locale":"en_US","og_type":"article","og_title":"CENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule one-on-one meetings. Please see additional details below: European Society of Gene & Cell Therapy (ESGCT) Annual Congress \u00a0 Dates: October 11-14, 2022 \u00a0 Location: Edinburgh International Conference Centre (EICC), U.K. \u00a0 Format: One-on-one meetings \u00a0 \u00a0 \u00a0 \u00a0 To learn more about the ESGCT Annual Congress, please visit the event website (https:\/\/www.esgctcongress.com\/). To set up a one-on-one meeting with the CENTOGENE … Continue reading \"CENTOGENE to Participate in Upcoming Partnering Conferences in October\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-06T10:10:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CENTOGENE to Participate in Upcoming Partnering Conferences in October","datePublished":"2022-10-06T10:10:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/"},"wordCount":706,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/","name":"CENTOGENE to Participate in Upcoming Partnering Conferences in October - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=","datePublished":"2022-10-06T10:10:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY2MDEwOCM1MTkwNDk3IzIxMjU1NDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centogene-to-participate-in-upcoming-partnering-conferences-in-october\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE to Participate in Upcoming Partnering Conferences in October"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692716"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692716\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}